Dr. James Song is the director of clinical research at Frontier Dermatology Partners in Everett, Mill Creek, and Monroe, Washington. Dr. Song is a clinical instructor at the University of Washington in Seattle, Washington. He is active in teaching medical students and resident physicians in training. He is also a clinical instructor for Silver Falls Dermatology located throughout Washington and Oregon. Dr. Song is board certified in Dermatology by the American Board of Physician Specialties.

Dr. Song received his bachelor of science degree in Neuroscience and his medical degree at the University of Illinois Chicago. He did a transitional year internship at MacNeal Hospital in Berwyn, Illinois, and then completed his dermatology residency at the University of California, Irvine in Irvine, California.

Dr. Song's primary clinical interest is in medical dermatology, including psoriasis, atopic dermatitis, vitiligo, alopecia areata, and hidradenitis suppurativa. Dr. Song is a regular contributor to the dermatology literature and speaks across the country as a key opinion leader. He believes that the best health outcomes come from shared decision-making between the patient and physician. 

Dr. Song discloses that he is a promotional speaker for AbbVie, Eli Lilly, Sanofi, Regeneron, Incyte, Pfizer, UCB, Sun, Novartis, Amgen, and Janssen. He also discloses that he is a consultant for AbbVie, Eli Lilly, Sanofi, Regeneron, Incyte, UCB, Sun, Novartis, Janssen, and Castle Biosciences. In addition, he discloses that he is an investigator for Sun. All relevant financial relationships have been mitigated.